Novo Holdings A/S 13D and 13G filings for Corvus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-07-09 4:29 pm Sale |
2020-07-07 | 13D | Corvus Pharmaceuticals, Inc. CRVS |
Novo Holdings A/S | 1,389,498 4.970% |
-1,538,062 (-52.54%) |
Filing |